A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma (Q24607479)
scientific article published on December 7, 2010
Language:
(P31) (Q13442814)
(P304) 341-7
(P407) (Q1860)
(P433) 2
(P478) 25
(P577) +2011-02-00T00:00:00Z
Tuesday, December 7, 2010
(P921) (Q42824440)
(P953) https://www.nature.com/articles/leu2010226.pdf
https://europepmc.org/articles/PMC3049870
https://europepmc.org/articles/PMC3049870?pdf=render
http://www.nature.com/articles/leu2010226.pdf
http://www.nature.com/articles/leu2010226
(P1433) (Q6534498)
(P1476) "A phase II trial of the oral mTOR inhibitor everolimus in relapsed aggressive lymphoma" (language: en)
(P2093) T. E. Witzig
C. B. Reeder
B. R. LaPlant
M. Gupta
P. B. Johnston
I. N. Micallef
L. F. Porrata
S. M. Ansell
J. P. Colgan
E. D. Jacobsen
I. M. Ghobrial
T. M. Habermann
(P2860) (Q29618031)
(Q29618608)
(Q34617756)
(Q33816583)
(Q33711127)
(Q37652233)
(Q39771144)
(Q34965132)
(Q33385283)
(Q40038511)
(Q34594224)
(Q33380246)
(Q33379949)
(Q36301583)
(Q36742629)
(Q40202733)
(Q36568861)
(Q40253260)
(Q40318856)
(Q36384467)
(Q40377835)
(Q33366976)
(Q40457592)
(Q33773306)
(Q33920766)
(Q42152675)
(Q41876102)
(Q46412217)
(Q25938997)
(Q43290574)
(Q80209074)
(Q105219584)
other details
description scientific article published on December 7, 2010

External Links